Skip to content

    Recently Viewed


      Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024

      Share Article
      share to

      New Brunswick, NJ (January 2, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2024 of $1.19 per share on the company’s common stock. The dividend is payable on March 5, 2024 to shareholders of record at the close of business on February 20, 2024. The ex-dividend date is February 16, 2024.

      About Johnson & Johnson
      At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at 

      Media contact:
      Tesia Williams

      Investor contact:
      Jessica Moore

      You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.